lubiprostone has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cremonini, F; Gras-Miralles, B | 1 |
| Merello, M; Perez-Lloret, S; Rossi, M | 1 |
| Davidson, A; Hunter, C; Jahan, I; Kenney, C; McCombs, A; Miller, A; Ondo, WG; Sullivan, K; Zesiewicz, TA | 1 |
2 review(s) available for lubiprostone and Parkinson Disease
| Article | Year |
|---|---|
A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.
Topics: Aged; Aged, 80 and over; Aging; Alprostadil; Analgesics, Opioid; Chronic Disease; Constipation; Female; Humans; Irritable Bowel Syndrome; Lubiprostone; Male; Parkinson Disease; Randomized Controlled Trials as Topic | 2013 |
Management of constipation in Parkinson's disease.
Topics: Alprostadil; Constipation; Defecation; Gastrointestinal Transit; Humans; Laxatives; Lubiprostone; Parkinson Disease; Polyethylene Glycols; Quality of Life | 2015 |
1 trial(s) available for lubiprostone and Parkinson Disease
| Article | Year |
|---|---|
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.
Topics: Aged; Alprostadil; Constipation; Double-Blind Method; Female; Follow-Up Studies; Humans; Lubiprostone; Male; Middle Aged; Parkinson Disease; Placebos; Severity of Illness Index; Treatment Outcome; Vasodilator Agents | 2012 |